Our research provides a distinctive mechanism facilitating incretin secretion from enteroendocrine cells and offers new strategies to enhance endogenous incretin secretion for the treatment of metabolic diseases such as diabetes and obesity. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.